NasdaqCM - Delayed Quote USD

VivoSim Labs, Inc. (VIVS)

2.0700
+0.1400
+(7.25%)
At close: May 16 at 4:00:01 PM EDT
2.0500
-0.02
(-0.97%)
After hours: May 16 at 6:37:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
122
109
370
1,500
0
Cost of Revenue
--
--
--
--
0
Gross Profit
--
--
--
--
0
Operating Expense
12,675
15,195
18,101
12,979
16,826
Operating Income
-12,558
-15,086
-17,731
-11,479
-16,826
Net Non Operating Interest Income Expense
175
405
454
8
15
Other Income Expense
--
12
20
25
-13
Pretax Income
-12,383
-14,669
-17,257
-11,446
-16,824
Tax Provision
2
2
2
2
2
Net Income Common Stockholders
-12,385
-14,671
-17,259
-11,448
-16,826
Diluted NI Available to Com Stockholders
-12,385
-14,671
-17,259
-11,448
-16,826
Basic EPS
-10.08
-19.20
-23.76
-15.84
-29.28
Diluted EPS
-10.08
-19.20
-23.76
-15.84
-29.28
Basic Average Shares
1,265.9640
762.0760
726.0850
725.2990
575.1660
Diluted Average Shares
1,265.9640
762.0760
726.0850
725.2990
575.1660
Total Operating Income as Reported
-12,558
-15,086
-17,731
-11,479
-16,826
Total Expenses
12,680
15,195
18,101
12,979
16,826
Net Income from Continuing & Discontinued Operation
-12,385
-14,671
-17,259
-11,448
-16,826
Normalized Income
-12,385
-14,683
-17,279
-11,448
-16,807
Interest Income
180
405
454
8
15
Net Interest Income
175
405
454
8
15
EBIT
-12,795
-15,086
-17,731
-11,479
-16,826
EBITDA
-12,519
-14,806
-17,438
-11,337
-16,785
Reconciled Cost of Revenue
--
--
--
--
0
Reconciled Depreciation
276
280
293
142
41
Net Income from Continuing Operation Net Minority Interest
-12,385
-14,671
-17,259
-11,448
-16,826
Total Unusual Items Excluding Goodwill
0
12
20
0
-19
Total Unusual Items
0
12
20
0
-19
Normalized EBITDA
-12,519
-14,818
-17,458
-11,337
-16,766
Tax Rate for Calcs
0.0002
0
0
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2021 - 2/14/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
 
CERO CERo Therapeutics Holdings, Inc.
0.5850
+0.22%
 
GRI GRI Bio, Inc.
1.5000
+3.45%
 
SNGX Soligenix, Inc.
1.8600
-4.12%
 
PTIX Protagenic Therapeutics, Inc.
3.0300
-2.88%
 
ENVB Enveric Biosciences, Inc.
1.3000
+1.56%
 
BDRX Biodexa Pharmaceuticals Plc
1.2800
-1.54%
 
LYRA Lyra Therapeutics, Inc.
0.1117
-0.98%
 
AVTX Avalo Therapeutics, Inc.
3.9100
+1.30%
 
AEON AEON Biopharma, Inc.
0.5000
+1.40%